Inhibition of GPX4 enhances CDK4/6 inhibitor and endocrine therapy activity in breast cancer.
Herrera-Abreu MT, Guan J, Khalid U, Ning J, Costa MR, Chan J, Li Q, Fortin JP, Wong WR, Perampalam P, Biton A, Sandoval W, Vijay J, Hafner M, Cutts R, Wilson G, Frankum J, Roumeliotis TI, Alexander J, Hickman O, Brough R, Haider S, Choudhary J, Lord CJ, Swain A, Metcalfe C, Turner NC.
Herrera-Abreu MT, et al. Among authors: fortin jp.
Nat Commun. 2024 Nov 5;15(1):9550. doi: 10.1038/s41467-024-53837-7.
Nat Commun. 2024.
PMID: 39500869
Free PMC article.